Renate Sekul
29Patents
15h-index
23Co-inventors
77Inventor score
Filing activity: Sep 29, 1997 → Jul 11, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6004925A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 139 | Expired |
| US6037323A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 139 | Expired |
| US6046166A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 71 | Expired |
| US6376464B1 | Lipid complexes of APO A-1 agonist compounds | Chemistry; Metallurgy | 60 | Expired |
| US6602854B1 | Branched multimeric Apo A-I agonist compounds | Chemistry; Metallurgy | 47 | Expired |
| US6265377A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 46 | Expired |
| US6753313B1 | Multimeric Apoa-I agonist compounds | Chemistry; Metallurgy | 41 | Expired |
| US6518412B1 | Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 38 | Expired |
| US6573239B1 | Apolipoprotein A-I agonist compounds | Chemistry; Metallurgy | 36 | Expired |
| US6734169B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 35 | Expired |
| US6329341A | Method of treating septic shock | Chemistry; Metallurgy | 34 | Expired |
| US6630450B1 | Method of treating dyslipidemia | Chemistry; Metallurgy | 33 | Expired |
| US6716816B1 | Multimeric Apo A-I agonist compounds | Chemistry; Metallurgy | 29 | Expired |
| US6844327B2 | Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 19 | Expired |
| US7956191B2 | 3-arylamino pyridine derivatives | Chemistry; Metallurgy | 15 | Active |
| US6900177B1 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 14 | Expired |
| US7312190B2 | Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 11 | Expired |
| US7189689B2 | Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 11 | Expired |
| US7211565B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 11 | Expired |
| US7273848B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 8 | Expired |
| US7250407B2 | Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 8 | Expired |
| US7307058B2 | Multimeric Apo A-I agonist compounds | Chemistry; Metallurgy | 7 | Expired |
| US8198457B2 | 3-arylamino pyridine derivatives | Chemistry; Metallurgy | 7 | Active |
| US8524911B2 | 3-arylamino pyridine derivatives | Chemistry; Metallurgy | 6 | Active |
| US7157425B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.